Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in
Advertisement

SciSparc Ltd. SPRC

Set alert

Price alert · SPRC

All alert types
0.68 USD -0.04 -5.05%

At close · Oct 30

0.65 -0.03 -3.87%

After hours · Oct 30, 7:48 PM ET

Bid
0.66 × 1
Ask
0.67 × 1
0.6031 Day range 0.6843
0.6763 52-week range 29.88
YTD
-94.47%
1 year
-97.69%
Open
0.6769
Prev close
0.7123
Mkt cap
392.91K
Vol
378.10K
Avg vol
1.34M
EPS
248.24
P/E
0.00
Div yield
0.00%
More statistics
Low
0.6031
High
0.6843
Forward P/E
0.00
Beta
1.04
Short ratio
0.22
Inst. own
1.73%
Dividend
0.00
Ex-div date
50-d avg
0.23526
200-d avg
0.77116
1y target
0.00

6M chart

Chart tools
Interval
1m5m15m30m

Signals (25)
NameDateAgo
RSI: OversoldOct 15, 20262 weeks ago
MACD: Sell SignalOct 12, 20262 weeks ago
MACD: Buy SignalSep 24, 20261 month ago
SMA: BearishSep 1, 20262 months ago
SMA: BearishSep 1, 20262 months ago
SMA: BullishAug 17, 20262 months ago
MACD: Sell SignalAug 14, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BullishAug 11, 20262 months ago
SMA: BearishAug 6, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishAug 4, 20262 months ago
SMA: BullishJul 29, 20263 months ago
SMA: BullishJul 29, 20263 months ago
MACD: Buy SignalJul 17, 20263 months ago
SMA: BearishJun 26, 20264 months ago
SMA: BearishJun 24, 20264 months ago
MACD: Sell SignalJun 12, 20264 months ago
SMA: BullishMay 28, 20265 months ago
SMA: BullishMay 28, 20265 months ago
MACD: Buy SignalMay 28, 20265 months ago
RSI: OverboughtMay 28, 20265 months ago
SMA: BearishMay 13, 20265 months ago
MACD: Sell SignalMay 7, 20265 months ago
SMA: BearishMay 4, 20266 months ago

Key statistics

Financials
Market cap
2.41M
Enterprise value
4.92K
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
1.38
Price / book
0.12
EPS (TTM)
-5.28
Beta
1.04
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.75M
Revenue growth
-57.40%
Free cash flow
-3.97M
Total cash
2.56M
Total debt
64.00K
Return on equity
-85.91%
Shares outstanding
10.36M
Short % of float
0.93%
50-day average
0.23526
200-day average
0.77116

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SPRC Revenue — quarterly 0
2018-Q4 2018
SPRC Net income — quarterly -4.37M
2018-Q4 2018
SPRC EPS — quarterly 1,375,920.00
2018-Q4 2018

About SciSparc Ltd.

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel
Website
scisparc.com

News

All news

Your note

Sign in to keep a note on SPRC — it syncs with the Stock Master app.

Institution ownership

SPRC institution ownership
Holder% heldSharesValueReported
UBS Group AG0.67%69,00616.06KSep 29, 2024
Two Sigma Securities, LLC0.36%37,0828.63KSep 29, 2024
Virtu Financial LLC0.14%14,1063.28KSep 29, 2024
Rhumbline Advisers0.03%3,464806Sep 29, 2024
Morgan Stanley0.00%23855Sep 29, 2024

Splits

SPRC stock splits
DateRatio
Mar 4, 20261:9
Jul 3, 20251:21
Sep 28, 20231:26
Advertisement